<ARTICLE>          5
<CIK>              0000722830
<NAME>             IMMUNOMEDICS, INC.
<MULTIPLIER>       1
       
                                         
<PERIOD-TYPE>                               3-MOS
<FISCAL-YEAR-END>                           JUN-30-1999
<PERIOD-START>                              JUL-01-1998
<PERIOD-END>                                SEP-30-1998
<CASH>                                          4,352,340
<SECURITIES>                                            0
<RECEIVABLES>                                   1,577,548
<ALLOWANCES>                                      (21,328)
<INVENTORY>                                       956,424
<CURRENT-ASSETS>                                7,344,301
<PP&E>                                         10,948,247
<DEPRECIATION>                                 (6,068,106)
<TOTAL-ASSETS>                                 12,224,442
<CURRENT-LIABILITIES>                           4,686,968
<BONDS>                                                 0
<PREFERRED-MANDATORY>                                   0
<PREFERRED>                                             0
<COMMON>                                          375,861
<OTHER-SE>                                      7,161,613
<TOTAL-LIABILITY-AND-EQUITY>                   12,224,442
<SALES>                                         1,667,272
<TOTAL-REVENUES>                                1,843,626
<CGS>                                              68,662
<TOTAL-COSTS>                                   4,772,229
<OTHER-EXPENSES>                                        0
<LOSS-PROVISION>                                        0
<INTEREST-EXPENSE>                                      0
<INCOME-PRETAX>                                (2,928,603)
<INCOME-TAX>                                            0
<INCOME-CONTINUING>                            (2,928,603)
<DISCONTINUED>                                          0
<EXTRAORDINARY>                                         0
<CHANGES>                                               0
<NET-INCOME>                                   (2,928,603)
<EPS-PRIMARY>                                       (0.08)
<EPS-DILUTED>                                       (0.08)